Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novo Nordisk

How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer, Eli Lilly

The Food and Drug Administration expanded the label for Novo Nordisk's oral diabetes medicine, leading NVO stock to jump Friday.

Investors Business Daily

Eli Lilly, insulin makers sued by California over prices

Eli Lilly & Co., Novo Nordisk AS and Sanofi were sued by California over insulin prices, which the state claims are inflated through unfair and deceptive practices and disproportionately affect low-income households and people of color.

Tribune News Service

California latest to sue drug companies over insulin prices

California says it will sue the companies that make and promote much of the nation's insulin

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

New guidance: Use drugs, surgery early for obesity in kids

New guidelines suggest children struggling with obesity should be evaluated and treated early and aggressively

The Independent UK

Semaglutide is causing a social media frenzy. So what is it?

It is not a a viral meme, but a drug that is an injectable medication — originally designed to treat diabetes — that has left those who need it waiting until next year for resupply.

ABC News

The growing market for weight loss drugs

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

Axios

Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly

Amgen is years behind rivals in developing an obesity treatment, but the company says its experimental drug could prove superior.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Amgen Is The Underdog In Obesity Treatment — But It's Creeping Up On Novo Nordisk, Eli Lilly

Amgen stock dipped Thursday though the company unveiled promising results for its experimental obesity treatment.

Investors Business Daily

Novo Nordisk Stock Flashing Renewed Technical Strength

Novo Nordisk ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Patients complain some obesity care startups offer pills, and not much else

Many Americans turn to the latest big idea to lose weight — fad diets, fitness crazes, dodgy herbs and pills, bariatric surgery, just to name a few. They’re rarely the magic solution people dream of.

Tribune News Service

Concerns rise over obesity care startups

Concerns emerge over a wave of new startups offering access to drugs called GLP-1 agonists

Salon

Weight loss drug causing chaos on TikTok

A diabetes drug is all the rage among Hollywood’s elite, but folks who need the drug are struggling to get it

Salon

Pharmaceutical companies’ stocks dive after verified imposter Twitter account claims ‘insulin is free’

Insulin producers Eli Lilly, Novo Nordisk and Sanofi all reported losses during Friday’s trading

The Independent UK

Eli Lilly Dives After Fake Twitter Account Promises Free Insulin; Takes Novo Nordisk, Sanofi With It

Twitter's new verification system shook Eli Lilly — leading LLY stock to skid Friday — after a fake account claimed "insulin is free now."

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - US

‘I miss eating’: the truth behind the weight loss drug that makes food repulsive

In Beverly Hills’ doctors offices, celebrities are clamoring for Ozempic prescriptions – but what are the costs of the supposed wonder drug?

Investors Business Daily

How Amgen Is Closing In On Rivals Novo Nordisk, Eli Lilly With Obesity Drug

Amgen stock jumped Tuesday on a promising update for its potential rival to obesity treatments from Novo Nordisk and Eli Lilly.

Investors Business Daily

How Novo Nordisk Is Trying To Lengthen Its Lead In Weight Loss Over Eli Lilly

Novo Nordisk is planning to boost production for weight-loss shot Wegovy as Eli Lilly angles for approval. NVO stock surged Wednesday.

Investors Business Daily

Amgen, The Big Name You Need To Know Going Up Against Novo, Lilly In Obesity Treatments

Amgen stock surged Tuesday on a reportedly bullish call for its experimental obesity treatment — a potential rival to Novo and Lilly.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

5 “Strong Buy” Health Care Stocks to Buy This Week

Rising prevalence of chronic diseases and the increasing aging population are significant growth drivers of the healthcare industry. Moreover, growing investments in technological advancements should bode well for the industry. Thus, we think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer (PFE), Novo Nordisk (NVO), Bristol-Myers Squibb (BMY),…

Investors Business Daily

Novo Nordisk Jumps Into Sickle Cell Fray With $1.1 Billion Forma Therapeutics Buyout

Novo Nordisk said Thursday it will spend $1.1 billion to acquire Forma in a deal that sent biotech stock Forma flying.

Investors Business Daily

Novo Nordisk's Obesity Sales Nearly Doubled, But That Wasn't Enough For NVO Stock

Danish drugmaker Novo Nordisk missed quarterly views Wednesday, but raised its full-year outlook. Still, NVO stock tumbled.

StockNews.com

3 Stocks No One Is Talking About but Should Be

Amid an uncertain market, it becomes increasingly difficult for investors to find stocks that can survive the challenges and deliver solid returns. Accel Entertainment (ACEL), Novo Nordisk (NVO), and Titan Machinery (TITN) are currently not on investors’ radar, but it could be worth adding these stocks to one’s portfolio given…

Investors Business Daily

Coal Stocks Today: Why Alliance Resource Partners Remains A Stock Market Leader

Fund ownership has been increasing at Alliance Resource in at least the past three quarters.

Financial Times

A new ‘miracle’ weight-loss drug really works — raising huge questions

Novo Nordisk’s Wegovy uses a hormone to regulate hunger. It’s wildly effective, but is it misguided?

Investors Business Daily

IBD Screen Of The Day: Mutual Funds Are Buying These Energy Stocks

Why solar, oil, and drug stocks may be ones to add to your watchlist.

1 … 24 25 26 27

People

Elon Musk

24,113 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.